golimumab
English
editEtymology
editFrom [Term?] + -lim- (“immunomodulating”) + -umab (“human monoclonal antibody”).
(This etymology is missing or incomplete. Please add to it, or discuss it at the Etymology scriptorium.)
Pronunciation
edit- (General American) IPA(key): /ɡoʊˈlɪm.jəˌmæb/
Noun
editgolimumab (uncountable)
- (pharmacology) A genetically engineered monoclonal antibody (trademark Simponi) that inhibits the activity of tumor necrosis factor and is administered by subcutaneous injection to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.
References
edit- “golimumab”, in Merriam-Webster Online Dictionary, Springfield, Mass.: Merriam-Webster, 1996–present.